CH579630A5 - - Google Patents

Info

Publication number
CH579630A5
CH579630A5 CH498673A CH498673A CH579630A5 CH 579630 A5 CH579630 A5 CH 579630A5 CH 498673 A CH498673 A CH 498673A CH 498673 A CH498673 A CH 498673A CH 579630 A5 CH579630 A5 CH 579630A5
Authority
CH
Switzerland
Application number
CH498673A
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of CH579630A5 publication Critical patent/CH579630A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
CH498673A 1972-04-06 1973-04-06 CH579630A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7212036A FR2181426B1 (de) 1972-04-06 1972-04-06

Publications (1)

Publication Number Publication Date
CH579630A5 true CH579630A5 (de) 1976-09-15

Family

ID=9096409

Family Applications (1)

Application Number Title Priority Date Filing Date
CH498673A CH579630A5 (de) 1972-04-06 1973-04-06

Country Status (13)

Country Link
US (1) US3925545A (de)
JP (1) JPS5549573B2 (de)
AT (1) AT332967B (de)
BE (1) BE797300A (de)
CA (1) CA1034496A (de)
CH (1) CH579630A5 (de)
DE (1) DE2316911C3 (de)
DK (1) DK143250C (de)
FR (1) FR2181426B1 (de)
GB (1) GB1422973A (de)
LU (1) LU67331A1 (de)
NL (1) NL7304219A (de)
YU (1) YU39706B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016252A (en) * 1972-04-06 1977-04-05 Institut Pasteur Calcium phosphate gel for adsorbing vaccines
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
DE2807132C2 (de) * 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
FR2502496A2 (fr) * 1981-03-30 1982-10-01 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon, et leur procede de preparation
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
FR2543439B1 (fr) * 1983-03-31 1985-09-27 Pasteur Institut Perfectionnement a la preparation d'un gel de phosphate de calcium utile a l'adsorption d'antigenes
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US8728536B2 (en) 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
ATE276199T1 (de) 1999-02-03 2004-10-15 Biosante Pharmaceuticals Inc Methoden zur herstellung von therapeutische kalzium-phosphat partikeln
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
US8221781B2 (en) 2003-04-11 2012-07-17 Etex Corporation Osteoinductive bone material
EP1720520B1 (de) 2004-02-13 2010-06-09 Nod Pharmaceuticals, Inc. Partikel mit kern aus calciumphosphat-nanopartikeln, biomolekül und gallensäure, herstellungsverfahren und therapeutische verwendung
AU2005249365B2 (en) 2004-04-15 2011-04-07 Etex Corporation Delayed-setting calcium phosphate pastes
WO2006050368A2 (en) * 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
FR2912396B1 (fr) * 2007-02-09 2011-08-26 Solvay Procede de production d'un reactif phosphocalcique, reactif obtenu et son utilisation
KR102032002B1 (ko) 2011-11-23 2019-10-14 머크 샤프 앤드 돔 코포레이션 알루미늄 히드록시포스페이트 아주반트의 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2364579A (en) * 1941-11-12 1944-12-05 Lederle Lab Inc Hog cholera vaccine
US3435112A (en) * 1966-06-21 1969-03-25 Norden Lab Inc Repository vaccine and method of preparing the same
FR1604134A (de) * 1967-09-26 1971-07-12

Also Published As

Publication number Publication date
JPS5549573B2 (de) 1980-12-12
FR2181426A1 (de) 1973-12-07
NL7304219A (de) 1973-10-09
LU67331A1 (de) 1973-06-15
CA1034496A (en) 1978-07-11
BE797300A (fr) 1973-09-26
DE2316911C3 (de) 1980-06-12
AT332967B (de) 1976-10-25
YU39706B (en) 1985-04-30
YU93473A (en) 1982-02-28
US3925545A (en) 1975-12-09
DE2316911A1 (de) 1973-10-25
JPS4913322A (de) 1974-02-05
DK143250B (da) 1981-08-03
ATA287173A (de) 1976-02-15
FR2181426B1 (de) 1974-12-20
DE2316911B2 (de) 1979-03-15
DK143250C (da) 1981-12-14
GB1422973A (en) 1976-01-28

Similar Documents

Publication Publication Date Title
FR2181426A1 (de)
FR2173977A1 (de)
CS156583B1 (de)
CS155432B1 (de)
CS155622B1 (de)
CS156140B1 (de)
CS156307B1 (de)
CS156974B1 (de)
CS156967B1 (de)
CS156923B1 (de)
CS156816B1 (de)
CS156348B1 (de)
CH563278A5 (de)
CH568695A5 (de)
CH560455A5 (de)
CH560531A5 (de)
CH560639A5 (de)
CH560905A5 (de)
CH560980A5 (de)
CH561196A5 (de)
CH561754A5 (de)
CH562373A5 (de)
CH562428A5 (de)
CH562541A5 (de)
CH560259B5 (de)

Legal Events

Date Code Title Description
PL Patent ceased